BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9486848)

  • 1. Regulation of transcriptional activation of mdm2 gene by p53 in response to UV radiation.
    Saucedo LJ; Carstens BP; Seavey SE; Albee LD; Perry ME
    Cell Growth Differ; 1998 Feb; 9(2):119-30. PubMed ID: 9486848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective p53 post-translational modification required for wild type p53 inactivation in malignant epithelial cells with mdm2 gene amplification.
    Knights CD; Liu Y; Appella E; Kulesz-Martin M
    J Biol Chem; 2003 Dec; 278(52):52890-900. PubMed ID: 14555661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The high levels of p53 present in adenovirus early region 1-transformed human cells do not cause up-regulation of MDM2 expression.
    Grand RJ; Lecane PS; Owen D; Grant ML; Roberts S; Levine AJ; Gallimore PH
    Virology; 1995 Jul; 210(2):323-34. PubMed ID: 7618270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of the p21/WAF-1 and mdm2 genes after high-dose UV irradiation: p53-dependent and p53-independent regulation of the mdm2 gene.
    Wu L; Levine AJ
    Mol Med; 1997 Jul; 3(7):441-51. PubMed ID: 9260156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defects in transcription coupled repair interfere with expression of p90(MDM2) in response to ultraviolet light.
    Michalowski J; Seavey SE; Mendrysa SM; Perry ME
    Oncogene; 2001 Sep; 20(41):5856-64. PubMed ID: 11593391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UV but not gamma irradiation accelerates p53-induced apoptosis of teratocarcinoma cells by repressing MDM2 transcription.
    Zeng X; Keller D; Wu L; Lu H
    Cancer Res; 2000 Nov; 60(21):6184-8. PubMed ID: 11085543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discordance between accumulated p53 protein level and its transcriptional activity in response to u.v. radiation.
    Lu X; Burbidge SA; Griffin S; Smith HM
    Oncogene; 1996 Jul; 13(2):413-8. PubMed ID: 8710381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA-damaging aryl hydrocarbons induce Mdm2 expression via p53-independent post-transcriptional mechanisms.
    Hsing A; Faller DV; Vaziri C
    J Biol Chem; 2000 Aug; 275(34):26024-31. PubMed ID: 10856296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDMX: a novel p53-binding protein with some functional properties of MDM2.
    Shvarts A; Steegenga WT; Riteco N; van Laar T; Dekker P; Bazuine M; van Ham RC; van der Houven van Oordt W; Hateboer G; van der Eb AJ; Jochemsen AG
    EMBO J; 1996 Oct; 15(19):5349-57. PubMed ID: 8895579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ets1 is required for p53 transcriptional activity in UV-induced apoptosis in embryonic stem cells.
    Xu D; Wilson TJ; Chan D; De Luca E; Zhou J; Hertzog PJ; Kola I
    EMBO J; 2002 Aug; 21(15):4081-93. PubMed ID: 12145208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 binds to a constitutively nucleosome free region of the mdm2 gene.
    Xiao G; White D; Bargonetti J
    Oncogene; 1998 Mar; 16(9):1171-81. PubMed ID: 9528859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased mdm-2 expression in a p53-independent manner blocks UV-induced cell cycle arrest and apoptosis in human osteosarcoma cells.
    Dong YB; Yang HL; Elliott MJ; McMasters KM
    Tumour Biol; 2003; 24(3):130-9. PubMed ID: 14610316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential activation of p53 targets in cells treated with ultraviolet radiation that undergo both apoptosis and growth arrest.
    Reinke V; Lozano G
    Radiat Res; 1997 Aug; 148(2):115-22. PubMed ID: 9254729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation.
    Stommel JM; Wahl GM
    EMBO J; 2004 Apr; 23(7):1547-56. PubMed ID: 15029243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive and DNA damage inducible activation of pig3 and MDM2 genes by tumor-derived p53 mutant C277Y.
    Pospísilová S; Siligan C; Ban J; Jug G; Kovar H
    Mol Cancer Res; 2004 May; 2(5):296-304. PubMed ID: 15192123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene.
    Juven T; Barak Y; Zauberman A; George DL; Oren M
    Oncogene; 1993 Dec; 8(12):3411-6. PubMed ID: 8247544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding.
    Midgley CA; Lane DP
    Oncogene; 1997 Sep; 15(10):1179-89. PubMed ID: 9294611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translation potential.
    Barak Y; Gottlieb E; Juven-Gershon T; Oren M
    Genes Dev; 1994 Aug; 8(15):1739-49. PubMed ID: 7958853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of human p53 at serine 46 determines promoter selection and whether apoptosis is attenuated or amplified.
    Mayo LD; Seo YR; Jackson MW; Smith ML; Rivera Guzman J; Korgaonkar CK; Donner DB
    J Biol Chem; 2005 Jul; 280(28):25953-9. PubMed ID: 15843377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the mdm2 oncogene by thyroid hormone receptor.
    Qi JS; Yuan Y; Desai-Yajnik V; Samuels HH
    Mol Cell Biol; 1999 Jan; 19(1):864-72. PubMed ID: 9858609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.